Interview with GATVAP: Open-Systems Dominate 80% of Market, Chinese Brands Like Innokin and Aspire Top the Charts

Industry Insight by 2FIRSTS
Sep.30.2024
Interview with GATVAP: Open-Systems Dominate 80% of Market, Chinese Brands Like Innokin and Aspire Top the Charts
Global Tobacco and Nicotine Forum (GTNF) held in Athens, Greece. E-cigarette market insights shared, emphasizing growth with regulation.

The 2024 Global Tobacco and Nicotine Forum (GTNF) was held in Athens, Greece from September 24th to 26th. During this edition of GTNF, 2Firsts engaged in discussions with industry professionals from the e-cigarette sector in Greece. Panos Panayiotopoulos, Chairman of the Greek Association of Traders for Vaping Products (GATVAP), shared insights with 2Firsts about the recent market trends in Greece, noting that the e-cigarette industry is experiencing rapid growth and increased regulation.

Interview with GATVAP: Open-Systems Dominate 80% of Market, Chinese Brands Like Innokin and Aspire Top the Charts
Panos Panayiotopoulos, General Manager of the GATVAPI

 

More than 80% of market dominated by open-systems, Chinese brands the most popular

 

Greece is one of the few European countries that does not tax tobacco products without nicotine. As a member of the EU, Greece's e-cigarette regulations align with the EU's Tobacco Products Directive (TPD). In November 2023, the Greek Ministry of Economy and Finance adjusted taxes on non-tobacco products containing nicotine, including "non-combustible electronic products" and "nicotine pouches".

 

Panos told 2Firsts that over 80% of the e-cigarettes in the Greek market are open system, as Greek consumers tend to prefer the freedom to choose flavors and open systems are more cost-effective. The economy is a significant influencing factor, with Greece's GDP per capita estimated to be around 23966 euros in 2023. In terms of GDP per capita, Greece is below the EU average and ranks in the lower half among EU countries.

 

When asked about which brands of e-cigarettes are most popular, Panos stated that the most popular brands on the market are mainly Chinese brands such as Innokin and Aspire.

 

In addition, he also mentioned that Greek importers tend to purchase e-cigarette products from within EU member countries rather than importing them from non-EU countries like the UK or the US, in order to streamline the process of getting the products into the Greek market.

 

Interview with GATVAP: Open-Systems Dominate 80% of Market, Chinese Brands Like Innokin and Aspire Top the Charts
A Greek online e-cigarette store sells products | Image source: 2Firsts

 

The market access fee for e-cigarette products has been set at 50 euros per SKU

 

According to Panos, e-liquids entering Greece must be registered with the European Poison Control Center. It is required that "each e-liquid formula must be unique" and have a 16-digit code to enter the database.

 

According to a search on the EU official website, the European Union advocates for the establishment of poison control centers in various countries in Europe. These institutions are responsible for providing emergency assistance, diagnosis, and treatment advice related to poisoning incidents. They typically receive inquiries from the public and medical professionals, especially in cases involving exposure to toxins, chemicals, drug overdoses, and animal or plant toxins.

 

Greece requires e-cigarette products to be registered and pay a disposable fee of 50 euros per SKU, also known as a "market access fee," before being sold on the market.

 

TPD is a disaster, but Greece has a huge demand for tobacco alternatives.

 

Panos stated that Greece, despite being a relatively small country, has 3.5 million smokers, leading to a significant demand in the market for cost-effective and efficient alternatives to traditional cigarettes, such as heated tobacco products and e-cigarettes.

 

In recent years, several international tobacco companies have entered the local market. Philip Morris International (PMI) previously stated that their investment plan in the Aspropyrgos factory in Greece since 2017 has significantly increased the production of IQOS products.

 

In November 2023, Japan Tobacco International (JTI) announced plans to invest approximately 3 billion euros (around 32 billion US dollars) in Greece over the next three years to expand their investment in heated tobacco products.

 

Panos believes that despite facing obstacles from the government, the market for aerosol tobacco products will continue to grow. They have witnessed the birth of TPD-2 and anticipate the arrival of TPD-3. Despite considering TPD to be a "disaster," the association believes that the market will continue to expand because millions of smokers need a safer alternative.

 

Meanwhile, Panos suggests that companies or brands interested in entering the e-cigarette market in Greece should familiarize themselves with local regulatory policies, adhere to market rules, and offer high-quality products.

 

Finally, Panos stated that GATVA's main goal is to serve as an official representative to advocate for the rights of vaping products to government agencies, the EU, and regulatory bodies. Its mission is to ensure that the Greek people have unhindered access to vaping products in order to facilitate the transition from traditional tobacco to alternative products.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26
Latest UK ONS Data: 54% of Vapers Are Former Cigarette Smokers, 26% Also Smoke and 20% Never Smoked Regularly
Latest UK ONS Data: 54% of Vapers Are Former Cigarette Smokers, 26% Also Smoke and 20% Never Smoked Regularly
Former cigarette smokers accounted for an estimated 54% of current e-cigarette users in Great Britain in 2025, while 26% also smoked cigarettes and 20% had never regularly smoked, according to a 2Firsts analysis of Office for National Statistics (ONS) data. Among former cigarette smokers who currently vape, approximately 81% used e-cigarettes daily, compared with about 50% of dual users. The ONS found that 33.8% of current cigarette smokers also vaped in 2025, up from 10.6% in 2014. Approximately 1.1 million adults who had never regularly smoked cigarettes used e-cigarettes, representing 2.9% of that population, compared with 0.2% in 2014. The figures highlight differences in the composition, frequency of use and long-term trends across Britain's vaping population.
DATA
Oct.14
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Philip Morris Japan (PMJ) launched the IQOS ILUMA i PRIME Ginza Limited Model Set in Tokyo on September 4, 2026, alongside the opening of IQOS Flagship Ginza, the brand’s first global flagship store. The Oasis Blue edition is limited to 1,814 individually numbered units, with the figure derived from the store’s address at Ginza 1-8-14. The set also includes two Yamanaka-nuri glasses and special packaging, priced at JPY 11,980 and sold exclusively at the Ginza flagship.
Sep.07
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Asia Manufacturing Corp. has invested ₱2.1 billion, or about $37 million, in its manufacturing site in Malvar, Batangas, Philippines, to expand tobacco-processing capabilities. About ₱1.9 billion is allocated to JTI's first Dry Ice Expanded Tobacco, or DIET, facility in Southeast Asia, while more than ₱177 million has been spent on expanding its Controlled Atmosphere treatment facility. The Batangas plant supplies the Philippine market and exports to 22 overseas markets, making it one of JTI's key manufacturing hubs in Asia.
Sep.24